CVS Health (CVS)
(Delayed Data from NYSE)
$57.40 USD
-0.28 (-0.49%)
Updated May 20, 2024 04:00 PM ET
Pre-Market: $57.47 +0.07 (0.12%) 8:46 AM ET
5-Strong Sell of 5 5
A Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$57.40 USD
-0.28 (-0.49%)
Updated May 20, 2024 04:00 PM ET
Pre-Market: $57.47 +0.07 (0.12%) 8:46 AM ET
5-Strong Sell of 5 5
A Value A Growth C Momentum A VGM
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
CVS Health (CVS) Q4 Earnings Top Estimates, 2024 EPS View Down
by Zacks Equity Research
Robust sales growth across all three operating segments contributes to CVS Health's (CVS) Q4 revenues.
Compared to Estimates, CVS Health (CVS) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for CVS Health (CVS) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Why Investors Need to Take Advantage of These 2 Retail and Wholesale Stocks Now
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Exploring Analyst Estimates for CVS Health (CVS) Q4 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Evaluate the expected performance of CVS Health (CVS) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $73.92, marking a -0.61% move from the previous day.
CVS Health (CVS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock
by Zacks Equity Research
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
by Zacks Equity Research
Sector ETF report for IHF
CVS Health (CVS) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
In the closing of the recent trading day, CVS Health (CVS) stood at $73, denoting a +1.4% change from the preceding trading day.
CVS Health (CVS) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
CVS Health's (CVS) fourth-quarter 2023 results are likely to reflect the strength of the Pharmacy & Consumer Wellness and Health Services segments.
CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
In the most recent trading session, CVS Health (CVS) closed at $73.22, indicating a -0.89% shift from the previous trading day.
Is Trending Stock CVS Health Corporation (CVS) a Buy Now?
by Zacks Equity Research
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
What's in the Cards for Fastenal (FAST) in Q4 Earnings?
by Zacks Equity Research
Fastenal's (FAST) Q4 results are likely to reflect manufacturing growth, albeit at a slow pace, with a strong digital strategy and a balanced onsite/offsite mix. Yet, slowing industrial markets are a concern.
How to Boost Your Portfolio with Top Retail and Wholesale Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Company News for Jan 12, 2024
by Nalak Das
Companies In the News Are: INFY, GOOGL, CVS, TGT, C.
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CVS Health (CVS) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
The latest trading day saw CVS Health (CVS) settling at $79.24, representing a -1.39% change from its previous close.
Zacks Industry Outlook Highlights CVS Health, Herbalife, Rite Aid and Amazon
by Zacks Equity Research
CVS Health, Herbalife, Rite Aid and Amazon are part of the Zacks Industry Outlook article.
Top Analyst Reports for Merck, Salesforce & Philip Morris
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Salesforce, Inc. (CRM) and Philip Morris International Inc. (PM).
3 Retail Pharmacy & Drugstore Stocks to Watch Amid Industry Headwinds
by Urmimala Biswas
Zacks Retail-Pharmacies and Drug Stores industry players like CVS, HLF and RADCQ are likely to gain despite reimbursement challenges that are hurting the overall industry health.
Should Invesco S&P 100 Equal Weight ETF (EQWL) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for EQWL
Here's Why CVS Health (CVS) Fell More Than Broader Market
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $80.51, moving -0.46% from the previous trading session.
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
by Zacks Equity Research
Sector ETF report for RSPH
CVS Health (CVS) Stock Moves -0.01%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $78.96, moving -0.01% from the previous trading session.